Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Liabilities and Shareholders Equity: 2021-2024

Historic Liabilities and Shareholders Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Dec 2024 value amounting to $180,199.

  • Molecular Partners Ag's Liabilities and Shareholders Equity fell 21.23% to $140,196 in Q3 2025 from the same period last year, while for Sep 2025 it was $628,177, marking a year-over-year decrease of 21.76%. This contributed to the annual value of $180,199 for FY2024, which is 18.41% down from last year.
  • Per Molecular Partners Ag's latest filing, its Liabilities and Shareholders Equity stood at $180,199 for FY2024, which was down 18.41% from $220,854 recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's Liabilities and Shareholders Equity peaked at $272,230 during FY2022, and registered a low of $180,199 during FY2024.
  • In the last 3 years, Molecular Partners Ag's Liabilities and Shareholders Equity had a median value of $220,854 in 2023 and averaged $224,427.
  • In the last 5 years, Molecular Partners Ag's Liabilities and Shareholders Equity spiked by 45.38% in 2022 and then fell by 18.87% in 2023.
  • Yearly analysis of 4 years shows Molecular Partners Ag's Liabilities and Shareholders Equity stood at $187,259 in 2021, then soared by 45.38% to $272,230 in 2022, then decreased by 18.87% to $220,854 in 2023, then dropped by 18.41% to $180,199 in 2024.